Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CAVA vs GSK✓SelectedUSD · GSKCAVA vs GSK performance historyLatest closeAs of-5.29%11/16
Stock and ETF performance explorer

CAVA vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+26.0%
GSK return
+65.4%
Excess return
-39.4%
Maximum drawdown
-71.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-5.3%-0.1%-5.2%-5.3%
7D-11.5%-1.3%-10.2%-11.4%
30D-3.7%+2.7%-6.4%-4.0%
3M-25.9%+2.7%-28.6%-26.2%
6M-28.3%+3.3%-31.6%-28.6%
YTD-6.0%+6.5%-12.5%-6.5%
1Y+16.8%+10.7%+6.1%+15.8%
3Y+60.9%+64.4%-3.5%+56.8%
All+26.0%+65.4%-39.4%+24.4%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling